Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Malik Kemal, Director. Officer active across 2 companies, notably Acceleron Pharma INC. In total, 4 reports have been logged. History available since 1 July 2024. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Kemal Malik serves as a Board Member at Acceleron Pharma Inc. In this role, he participates in overseeing the company's activities and making strategic decisions. His experience in the pharmaceutical sector allows him to provide valuable insights to guide Acceleron in its innovation and development initiatives. He plays a key role in the governance of the company.